Log in or Sign up for Free to view tailored content for your specialty!
ADD/ADHD News
Lisdexamfetamine dimesylate, behavioral treatment combination effective for family ADHD
A combination of medication and behavioral treatments may benefit multiplex families where both children and their mothers have ADHD, according to study results published in Journal of Clinical Psychiatry.
Black individuals at higher risk for ADHD vs. general population
Black individuals appeared at higher risk for ADHD diagnoses compared with the general U.S. population, according to results of a systematic review and meta-analysis published in JAMA Psychiatry.
Log in or Sign up for Free to view tailored content for your specialty!
Adolescent exposure to endocrine-disrupting chemicals linked to ADHD-related behaviors
Exposure to endocrine-disrupting chemicals, particularly phthalates, was linked to ADHD-related behaviors among adolescents, according to results of a cross-sectional analysis published in JAMA Network Open.
Autoimmune disease more prevalent in patients with juvenile arthritis vs. ADHD
Patients with juvenile idiopathic arthritis are more likely to develop concurrent autoimmune disease than those with attention deficit hyperactivity disorder, according to data published in Pediatric Rheumatology.
Important updates for Minority Mental Health Awareness Month
In 2008, the U.S. House of Representatives designated July as Bebe Moore Campbell National Minority Mental Health Awareness Month.
FDA clears video game therapy for ADHD
The FDA has granted marketing authorization for the first time for a video game that can improve the attention span in children with ADHD.
Confounders significantly weaken association between in utero antidepressant exposure and adverse child outcomes
Adverse psychiatric, neurodevelopmental and physical outcomes among children reportedly associated with in utero exposure to antidepressants appeared to be caused by the underlying maternal disorder, according to results of a systematic review published in Journal of Clinical Psychiatry.
Earth Day: Mental health and the natural world
Each year, April 22 is recognized as Earth Day — an observance held to highlight support and raise awareness for environmental protection.
Guanfacine extended-release effective, safe for adult ADHD
Guanfacine extended-release was associated with significant improvement in adult ADHD symptoms without any major safety concerns, according to results of a randomized, double-blind, placebo-controlled trial conducted in Japan and published in Journal of Clinical Psychiatry.
PCPs play key role in autism
The CDC recently announced that 1 in 54 children aged 8 years in 2016 had autism in the United States. The previous estimate for that age was 1 in 59 children in 2014 and 1 in 68 children in 2010.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read